Literature DB >> 8489340

The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.

P H Gilligan1, T P Walden, W F Kelly, K J Wait, J A Kraft, D H Willis.   

Abstract

A commercially available enzyme immunoassay (EIA) for the detection of Clostridium difficile toxin A (Premier Toxin A EIA, Meridian Diagnostics, Cincinnati, Ohio) was compared with tissue culture cytotoxicity assay, enterotoxigenic culture, and latex agglutination test for the laboratory diagnosis of C difficile-associated disease. When evaluated for detection of C difficile-associated disease using clinical specimens, EIA was the most sensitive (83.1%) and tissue culture cytotoxicity assay was the most specific test with EIA, tissue culture cytotoxicity assay and enterotoxigenic culture having similar correlation values (96.6, 96.1, 94.0%, respectively). The latex agglutination test was not as accurate (89.7% correlation) as the other three tests due mainly to its poor sensitivity (47.9%). The EIA is a rapid, easy-to-use alternative to tissue culture cytotoxicity assay for detection of C difficile-associated disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489340

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A.

Authors:  S O Vargas; D Horensky; A B Onderdonk
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

2.  Biographical Feature: Peter H. Gilligan, Ph.D., D(ABMM), F(AAM).

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

3.  Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.

Authors:  J L Staneck; L S Weckbach; S D Allen; J A Siders; P H Gilligan; G Coppitt; J A Kraft; D H Willis
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases.

Authors:  S Whittier; D S Shapiro; W F Kelly; T P Walden; K J Wait; L T McMillon; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.